Author = Alireza Emami Ardekani
Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature

Volume 10, Issue 2, June 2022, Pages 91-99

10.22038/aojnmb.2022.61517.1433

Bahare Saidi; Babak Fallahi; Armaghan Fard-Esfahani; Alireza Emami-Ardekani; Mohammad Eftekhari


A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer

Volume 9, Issue 2, July 2021, Pages 101-110

10.22038/aojnmb.2020.52375.1358

Sara Harsini; Babak Fallahi; Najme Karamzade ziarati; Ali Razi; Erfan Amini; Alireza Emami Ardekani; Armaghan Fard Esfehani; Mehdi Kardoust Parizi; saeed farzanehfar; Davood Beiki


Potential role of 18F-FDG PET/CT in a case of progressive Rosai Dorfman disease

Volume 9, Issue 1, January 2021, Pages 62-66

10.22038/aojnmb.2020.51742.1356

Armaghan Fard-Esfahani; Bahare Saidi; Sara Seyedinia; Alireza Emami Ardekani; Mohammad Eftekhari


68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors

Volume 8, Issue 1, January 2020, Pages 8-17

10.22038/aojnmb.2019.41343.1280

Pezhman Shahrokhi; Alireza Emami-Ardekani; Sara Harsini; Mohammad Eftekhari; Armaghan Fard Esfehani; Babak Fallahi; Najme Karamzade Ziarati; Mehdi Akhlaghi; Saeed Farzanefar; Davood Beiki; Amir Pejman Hashemi Taheri


Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors

Volume 7, Issue 2, July 2019, Pages 129-140

10.22038/aojnmb.2019.39392.1263

Babak Fallahi; Reyhaneh Manafi-Farid; Mohammad Eftekhari; Armaghan Fard-Esfehani; Alireza Emami-Ardekani; Parham Geramifar; Mehdi Akhlaghi; Amir Pejman Hashemi Taheri; Davood Beiki